|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Multiple Sclerosis | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Hypercapnia | |||||
| Sclerosis | |||||
| 3 | More general conditions related to this trial | ||||
| Autoimmune Diseases | |||||
| Autoimmune Diseases of the Nervous System | |||||
| Demyelinating Autoimmune Diseases, CNS | |||||
| Demyelinating Diseases | |||||
| Immune System Diseases | |||||
| Nervous System Diseases | |||||
| Pathologic Processes | |||||
| Signs and Symptoms | |||||
| Signs and Symptoms, Respiratory | |||||
| 4 | Sponsors listed in this trial | ||||
| National Institutes of Health Clinical Center (CC) | |||||